Major Brokerage Firms Issue Research Notes on HCA Healthcare Inc. (HCA)


HCA Healthcare Inc. (NYSE:HCA) saw a downside of -4.22% to close Tuesday at $252.68 after subtracting -$11.13 on the day. The 5-day average trading volume is 1,775,800 shares of the company’s common stock. It has gained $269.09 in the past week and touched a new high 2 times within the past 5 days. An average of 1,217,480 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,210,296.

HCA’s 1-month performance is 4.03% or $11.94 on its low of $236.27 reached on 12/28/22. The company’s shares have touched a 52-week low of $164.47 and high of $279.02, with the stock’s rally to the 52-week high happening on 01/23/23. YTD, HCA has achieved 5.30% or $12.72 and has reached a new high 9 times. However, the current price is down -9.44% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Insider Transactions

HCA stock investors last saw insider trading activity on Nov 11.MOORE A BRUCE JR (Group President – Service Line) most recently sold 10,000 shares at $224.07 per share on Nov 11. This transaction cost the insider $2,240,690. Group President, Hall Charles J, sold 9,838 shares at a price of $223.50 on Oct 28. Then, on Oct 28, SVP; Chief Development Officer Sowell Joseph A III sold 12,946 shares at a price of $223.18 per share. This transaction amounted to $2,889,304.

Valuation Metrics

HCA stock has a beta of 1.65. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.17 while the price to cash flow ratio at 19.90.

HCA Healthcare Inc.’s quick ratio for the period ended September 29 was 1.20, with the current ratio over the same period at 1.40.. In terms of profitability, the gross margin trailing 12 months is 84.40%. The firm’s gross profit as reported stood at $49.27 billion against revenue of $58.75 billion.

Earnings Surprise

For the quarterly period ending September 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -27.87% to $1.13 billion, while revenue of $1.16 billion was -1.85% off the previous quarter. Analysts expected HCA to announce $3.88 per share in earnings in its latest quarter, but it posted $3.93, representing a 1.30% surprise. EBITDA for the quarter stood at more than $2.91 billion. HCA stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 52.26 billion, with total debt at $39.47 billion. Shareholders hold equity totaling $282.72 million.

Let’s look briefly at HCA Healthcare Inc. (HCA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 49.16% to suggest the stock is trending Neutral, with historical volatility in this time period at 27.27%.

The stock’s 5-day moving average is $258.33, reflecting a -2.18% or -$5.64 change from its current price. HCA is currently trading +4.78% above its 20-day SMA, +25.23% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +20.89% and SMA200 by+0.88%.

Stochastic %K and %D was 70.58% and 79.66% and the average true range (ATR) pointed at 6.76. The RSI (14) points at 54.23%, while the 14-day stochastic is at 34.80% with the period’s ATR at 6.32. The stock’s 9-day MACD Oscillator is pointing at 1.93 and 4.28 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for HCA Healthcare Inc. (NYSE: HCA), BMO Capital Markets downgraded it to an Underperform rating. They previously had a Market perform rating on the stock.


Please enter your comment!
Please enter your name here